Related references
Note: Only part of the references are listed.Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
Charles J. Sande et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2013)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease
E. O. Ohuma et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993-2008
Hong Zhou et al.
CLINICAL INFECTIOUS DISEASES (2012)
Vaccine-Elicited CD8+ T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c Mice
Sujin Lee et al.
JOURNAL OF VIROLOGY (2012)
The Secreted G Protein of Human Respiratory Syncytial Virus Antagonizes Antibody-Mediated Restriction of Replication Involving Macrophages and Complement
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2012)
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
Margarita Magro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis
Anne L. Hotard et al.
VIROLOGY (2012)
Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective
Parthiv J. Mahadevia et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children
Chadi M. El Saleeby et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice
Kate L. Stokes et al.
JOURNAL OF VIROLOGY (2011)
Respiratory Syncytial Virus Interferon Antagonist NS1 Protein Suppresses and Skews the Human T Lymphocyte Response
Shirin Munir et al.
PLOS PATHOGENS (2011)
A Systemic Neutrophil Response Precedes Robust CD8+ T-Cell Activation during Natural Respiratory Syncytial Virus Infection in Infants
Michael V. Lukens et al.
JOURNAL OF VIROLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I
Zhenhua Ling et al.
JOURNAL OF VIROLOGY (2009)
A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction
Martin L. Moore et al.
JOURNAL OF VIROLOGY (2009)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses
Timothy P. Welliver et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction
M Ramaswamy et al.
VIROLOGY (2006)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
RA Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
